Squarepoint’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,725
Closed -$789K 4639
2023
Q4
$789K Buy
+14,725
New +$745K ﹤0.01% 2697
2021
Q4
Sell
-2,385
Closed -$220K 3544
2021
Q3
$220K Buy
+2,385
New +$229K ﹤0.01% 2432
2021
Q2
Sell
-3,758
Closed -$367K 3720
2021
Q1
$367K Sell
3,758
-3,722
-50% -$339K ﹤0.01% 2255
2020
Q4
$577K Sell
7,480
-43,958
-85% -$3.4M ﹤0.01% 1709
2020
Q3
$3.79M Buy
51,438
+47,023
+1,065% +$3.77M 0.05% 426
2020
Q2
$324K Sell
4,415
-11,525
-72% -$904K 0.01% 1558
2020
Q1
$921K Sell
15,940
-377
-2% -$26.2K 0.02% 750
2019
Q4
$1.28M Sell
16,317
-20,930
-56% -$1.54M 0.01% 1184
2019
Q3
$2.55M Buy
37,247
+10,147
+37% +$681K 0.02% 748
2019
Q2
$2.15M Sell
27,100
-941
-3% -$74.6K 0.02% 802
2019
Q1
$2.35M Buy
28,041
+13,864
+98% +$1.45M 0.02% 713
2018
Q4
$1.67M Sell
14,177
-4,973
-26% -$575K 0.02% 739
2018
Q3
$2.31M Buy
19,150
+2,811
+17% +$349K 0.03% 670
2018
Q2
$1.88M Buy
+16,339
New +$1.79M 0.03% 653
2018
Q1
Sell
-4,083
Closed -$302K 2166
2017
Q4
$302K Buy
+4,083
New +$273K 0.01% 1503
2017
Q2
Sell
-3,776
Closed -$217K 1820
2017
Q1
$217K Sell
3,776
-2,852
-43% -$170K 0.01% 1253
2016
Q4
$406K Buy
+6,628
New +$432K 0.02% 946
2015
Q3
Sell
-3,000
Closed -$205K 587
2015
Q2
$205K Buy
+3,000
New +$190K 0.07% 369

Other funds holding USNA

Squarepoint's USNA Position: Q1 2024 in Review

Squarepoint sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 14,725 shares — an estimated $789K sold.

Squarepoint first reported a position in USNA in Q2 2015 and held it in 18 quarters. The position peaked at $3.79M in Q3 2020. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

  • Squarepoint reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
  • Squarepoint sold 14,725 Usana Health Sciences shares in Q1 2024, an estimated $789K.
  • Squarepoint first reported a position in Usana Health Sciences in Q2 2015 and held it in 18 quarters.
  • Squarepoint's Usana Health Sciences position peaked at $3.79M in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.